Article Versions Notes

Osher E, Shalabna E, Klausner JM, Greenman Y, Stern N, Shibolet O, Scapa E, Yakir O, Shor DB-A, Bar-Yishay I, et al. A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors. Biomedicines. 2023; 11(2):407. https://doi.org/10.3390/biomedicines11020407

Osher, Esther, Eiman Shalabna, Joseph M. Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, and et al. 2023. "A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors" Biomedicines 11, no. 2: 407. https://doi.org/10.3390/biomedicines11020407

Osher, E., Shalabna, E., Klausner, J. M., Greenman, Y., Stern, N., Shibolet, O., Scapa, E., Yakir, O., Shor, D. B.-A., Bar-Yishay, I., Shamai, S., Sofer, Y., Lubezky, N., Goykhman, Y., Lahat, G., Wolf, I., Pelles, S., Aizic, A., Blachar, A., & Geva, R. (2023). A Lymph Node Ratio Model for Prognosis of Patients with Pancreatic Neuroendocrine Tumors. Biomedicines, 11(2), 407. https://doi.org/10.3390/biomedicines11020407